Skip to content

MBX Biosciences, Inc. MBX Retained Earnings

Retained Earnings at other companies

Eli Lilly logo
Eli LillyLLY
$29.51B+95.5%
Amgen logo
AmgenAMGN
-$24.65B+9.2%
Viking Therapeutics logo
Viking TherapeuticsVKTX
-$1.01B-88.5%
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
-$792.71M-23.4%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$3.99B-22.1%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
-$1.09B-37.1%

Other financials

Income statement

See full
Operating income-$27.3M-2.8%
Net income-$23.5M+1.5%
EPS (diluted)-$0.50+29.6%

Balance sheet

See full
Cash & equivalents$45.2M+51.2%
Total debt$555.0K+327%
Total equity$437.8M+85.9%
Total assets$452.7M+84.1%

Cash flow

See full
Operating cash flow-$20.2M+10.9%
CapEx$437.0K+1,357%
Free cash flow-$20.6M+9.1%

Valuation

See full
Market cap$2.21B+475%
Enterprise value$2.16B+533%

Returns & leverage

See full
Return on equity-25.7%
Debt / equity0.0×
Current ratio30.8×+7.5×

Where this comes from

Reported directly by MBX Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about MBX Biosciences, Inc.'s retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MBX Biosciences, Inc.'s retained earnings?
MBX Biosciences, Inc. (MBX) reported retained earnings of -$247.99M in Q1 2026.
How has MBX Biosciences, Inc.'s retained earnings changed year-over-year?
MBX Biosciences, Inc.'s retained earnings decreased by 53.7% year-over-year, from -$161.39M to -$247.99M.
What is the long-term trend for MBX Biosciences, Inc.'s retained earnings?
Over 2 years (2023 to 2025), MBX Biosciences, Inc.'s retained earnings has grown at a 72.3% compound annual growth rate (CAGR), from -$75.58M to -$224.48M.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.